Viewing StudyNCT04439110



Ignite Creation Date: 2024-05-06 @ 2:49 PM
Last Modification Date: 2024-10-26 @ 1:38 PM
Study NCT ID: NCT04439110
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-08
First Post: 2020-06-18

Brief Title: Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes MATCH-Subprotocol Q
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-08-12
Start Date Type: ACTUAL
Primary Completion Date: 2019-03-09
Primary Completion Date Type: ACTUAL
Completion Date: 2025-03-07
Completion Date Type: ESTIMATED
First Submit Date: 2020-06-18
First Submit QC Date: June 18 2020
Study First Post Date: 2020-06-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2021-02-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-02
Last Update Post Date: 2024-05-08
Last Update Post Date Type: ACTUAL